GSK - GlaxoSmithKline plc

NYSE - NYSE Delayed Price. Currency in USD

GlaxoSmithKline plc

980 Great West Road
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
http://www.gsk.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees98,462

Key Executives

NameTitlePayExercisedYear Born
Ms. Emma WalmsleyCEO & Director3.92M428.24k1970
Mr. Simon P. DingemansCFO & Exec. Director2.83M648.98k1964
Mr. Jack BaileyPres of US PharmaceuticalsN/AN/AN/A
Ms. Karenann K. TerrellChief Digital & Technology OfficerN/AN/A1961
Dr. Hal V. BarronChief Scientific Officer, Pres of R&D and DirectorN/AN/A1963
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; and a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate Governance

GlaxoSmithKline plc’s ISS Governance QualityScore as of November 1, 2018 is 9. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.